Avanos Medical, Inc. and American Industrial Partners (AIP) have jointly announced a significant milestone in their pending merger: the receipt of all necessary regulatory approvals. This clearance paves the way for the acquisition of Avanos by affiliates of investment funds advised by AIP.
The transaction is now slated to close by July 27, 2026, contingent on approval from Avanos stockholders and the fulfillment of other standard closing conditions. A crucial step in this process is the special meeting for Avanos stockholders, scheduled for July 22, 2026, where the deal will be put to a vote.
David C. Pacitti, CEO of Avanos, expressed satisfaction with the progress, noting the strong collaboration that led to securing these approvals. He anticipates the transaction will usher in a new era of innovation and growth for the company. Joel Rotroff, Partner at AIP, echoed this sentiment, stating his enthusiasm for partnering with Avanos’s leadership team to further the company’s mission in delivering medical device solutions.
Avanos Medical, Inc., headquartered in Alpharetta, Georgia, is recognized for its clinically superior medical device solutions. American Industrial Partners is a private equity firm with approximately $17.8 billion in assets under management, focusing on industrials and engineered products businesses.
About the Author
